Beijing Science Sun Pharmaceutical Co Ltd (300485) — Long-term Investment Intensity

Latest as of September 2019: 13.0%

Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Long-term Investment Intensity of 13.0% as of September 2019. Long-term investments of CN¥359.33 Million represent 13.0% of total assets of CN¥2.77 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 300485 net asset value for net asset value and shareholders' equity analysis.

LT Investment Intensity

13.0%
LT Investments / Total Assets

Long-term Investments

CN¥359.33 Million
CNY

Total Assets

CN¥2.77 Billion
CNY

Country

China
SHE

Beijing Science Sun Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 13.0%, reflecting long-term investments of CN¥359.33 Million against total assets of CN¥2.77 Billion CNY. Also explore Beijing Science Sun Pharmaceutical Co Lt assets under control for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Beijing Science Sun Pharmaceutical Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Beijing Science Sun Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Beijing Science Sun Pharmaceutical Co Lt worth.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 9.5% CN¥262.03 Million CN¥2.76 Billion ▲ +0.1 pp
2017 9.4% CN¥230.66 Million CN¥2.45 Billion ▼ -0.1 pp
2016 9.5% CN¥210.09 Million CN¥2.22 Billion ▲ +4.1 pp
2015 5.4% CN¥105.00 Million CN¥1.94 Billion
pp = percentage points